During an open surgery, experienced surgeons can detect tumorous tissues just by touching them. This knowledge is the result of many years’ experience. Although minimally invasive surgeries have numerous benefits, including shorter recovery times and fewer post-surgical complications, surgeons lose the ability to touch and the benefits of touching. The Sensobright Laparoscopic Surgery System, – thanks to our artificial intelligence software – carries the surgeons’ priceless experience to other surgeons via “sensitive and trained” laparoscopic devices.

The Sensobright Laparoscopıc Surgery System is composed of a processor that runs our artificial intelligent software and an add-on apparatus designed for laparoscopic devices. The add-on apparatus contains a specifically designed version of our 100+ granted patented, many awards winning, highly sensitive, tactile and temperature sensors. it can be attached to the laparoscopy device without changing its shape or size. During minimally invasive surgeries, the sensory system warns doctors, if the critical threshold of force application is exceeded and a potential tumor or internal bleeding is detected, which can lead to surgery-influenced metastasis. The warning also includes information about their growth direction, which helps doctors determine the source of the tumor.

Statistically, surgeons are expected to serve at least five years in order to be “experienced” and perform hundreds of surgeries during this period. As our technology carries the priceless experience to other surgeons through “sensitive and trained” laparoscopic devices, the success rate will increase dramatically during their first 5 years’ laparoscopic surgeries.

Recent studies demonstrate that, if necessary precautions were taken to prevent surgery-influenced metastasis, in the US alone in 2022, an additional 21% of patients, or about 240,000 people, undergoing surgery could be totally cured. in other words, insurance companies and the US government could save roughly $24 Billion in health-care spending. lf our system is used in cancer-focused minimally invasive surgeries – in the United States alone – it has the potential to save a majority of these 240,000 lives as well as a significant amount of these $24 Billion in health care spending each year.